Optimization of Treatment Strategy for Unresectable cN3 Esophageal Squamous Cell Carcinoma

Clinical trial NCT06122493 · RECRUITING

Trial details

NCT number: NCT06122493
Sponsor: Ruijin Hospital
Status: RECRUITING
Phase: Phase 2
Study type: INTERVENTIONAL

Esophageal Squamous Cell Carcinoma

Start date: 2022-11-01
Primary completion: 2026-11-01
Enrollment: 48

View on ClinicalTrials.gov

Track trials programmatically

Sponsors, conditions and status changes through the Atlas API.